Long-term follow-up and quality of life after cancer treatment
Part of Cancer clinical trials.
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being treated with an innovative or expensive anticancer drug.
- You are also receiving non-drug treatments at the Rafael Institute.
- You understand French.
- You are not in prison, under guardianship, or unable to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study follows people with anal cancer to understand how their quality of life changes after they receive standard chemoradiation therapy. It may help doctors better support patients with symptoms, recovery, and daily functioning over time.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This observational study follows people with esophageal cancer to see how their quality of life changes after chemoradiation. It does not change your treatment, but it may help doctors better understand what to expect during and after therapy.
This study tests whether having regular check-ins on your quality of life (like symptoms and daily well-being) can help you feel better during lung cancer treatment. It's for patients recently diagnosed with lung cancer who are getting care at select hospitals in Bavaria.
This study follows people with advanced neuroendocrine tumors (NETs) that cannot be removed by surgery or have spread. Its goal is to see how long patients can live without having serious side effects from treatment, so doctors can better understand which treatments are worth the risks.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.